Status:
NOT_YET_RECRUITING
Optimal Injection Interval for Intra-Detrusor Botulinum Toxin
Lead Sponsor:
Louisiana State University Health Sciences Center in New Orleans
Conditions:
Overactive Bladder
Urinary Urgency
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to see if patients deciding their own follow up times can increase the effectiveness of botulinum toxin (BTX or "Botox") injection for overactive bladder (OAB). The ...
Detailed Description
Overactive bladder (OAB) is defined by symptoms of urinary urgency, frequency, or nocturia with or without incontinence in the absence of urinary tract infection or other attributable pathology. This ...
Eligibility Criteria
Inclusion
- diagnosis of overactive bladder, detrusor overactivity, urinary urgency, urinary frequency, nocturnal polyuria, or urge urinary incontinence
- pursuing treatment with intravesical botulinum toxin injections
Exclusion
- \- non-OAB diagnosis such as pelvic pain or interstitial cystitis
Key Trial Info
Start Date :
July 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06483217
Start Date
July 1 2024
End Date
October 1 2025
Last Update
July 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Louisiana State University Health Science Center
New Orleans, Louisiana, United States, 70112